PACT Pharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.pactpharma.com
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Phase 1
Suspended
- Conditions
- Solid Tumor
- Interventions
- Biological: NeoTCR-P1 adoptive cell therapyBiological: IL-2Biological: nivolumab
- First Posted Date
- 2019-05-31
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- PACT Pharma, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT03970382
- Locations
- 🇺🇸
Tennessee Oncology, Nashville, Tennessee, United States
🇺🇸University of California, Los Angeles, Los Angeles, California, United States
🇺🇸University of California, Davis, Sacramento, California, United States
© Copyright 2025. All Rights Reserved by MedPath